Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as many cancers use the TME to build barriers that shield immune syste... Read more
Cellares
4 followers
Tango Therapeutics
3 followers
Dyno Therapeutics
4 followers
Odyssey Therapeutics
2 followers
Gilead Sciences
159 followers
Regeneron
130 followers
Illumina
79 followers
Agilent Technologies
81 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
45 followers
GRAIL
28 followers
Explore companies